nnc 711 has been researched along with 3-aminopropylphosphinic acid in 1 studies
Studies (nnc 711) | Trials (nnc 711) | Recent Studies (post-2010) (nnc 711) | Studies (3-aminopropylphosphinic acid) | Trials (3-aminopropylphosphinic acid) | Recent Studies (post-2010) (3-aminopropylphosphinic acid) |
---|---|---|---|---|---|
112 | 0 | 21 | 30 | 0 | 2 |
Protein | Taxonomy | nnc 711 (IC50) | 3-aminopropylphosphinic acid (IC50) |
---|---|---|---|
Gamma-aminobutyric acid type B receptor subunit 2 | Rattus norvegicus (Norway rat) | 0.0052 | |
Gamma-aminobutyric acid type B receptor subunit 1 | Rattus norvegicus (Norway rat) | 0.0051 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kerr, DI; Ong, J | 1 |
1 other study(ies) available for nnc 711 and 3-aminopropylphosphinic acid
Article | Year |
---|---|
The gamma-aminobutyric acid uptake inhibitor NO-711 potentiates 3-aminopropylphosphinic acid-induced actions in rat neocortical slices.
Topics: Animals; Dose-Response Relationship, Drug; Drug Synergism; Electrophysiology; GABA Agonists; GABA Antagonists; In Vitro Techniques; Male; Neocortex; Nipecotic Acids; Organophosphorus Compounds; Oximes; Rats; Rats, Sprague-Dawley | 1998 |